Concepedia

Fadia Qiryaqos

FQ

Statistics

Publications

1

Citations

22

H-Index

1

Active since

2024

Affiliations

Mirati Therapeutics (United States)(Current)

Fadia Qiryaqos is an author at Mirati Therapeutics (United States) specializing in cancer research, lung cancer, and tumor biology.

ORCID

Top concepts

Publications per year

2024–2024

1

Publications

1

The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading

Niranjan Sudhakar, Larry Yan, Fadia Qiryaqos et al. · Molecular Cancer Therapeutics · 2024 · 22 citations · Full text

, , +17

1–1 of 1